Zeal Global Opportunities Fund FCCB sold over 5.8 crore shares, reducing its stake in Evexia Lifecare Ltd by 3.09%. The transaction occurred via open market sales between June 1 and June 8, 2026. This reduces the institutional investor's holding to 4.78%.

Evexia Lifecare: Zeal Global Fund Divests Over 5.8 Crore Shares

Zeal Global Opportunities Fund FCCB has sold 5,80,02,545 shares of Evexia Lifecare Ltd, reducing its stake by 3.09% through open market transactions. The sale took place between June 1, 2026, and June 8, 2026.

Reader Takeaway: Institutional stake reduced; increased market float for Evexia Lifecare.

What just happened

Zeal Global Opportunities Fund FCCB, a non-promoter entity, offloaded a significant block of shares in Evexia Lifecare Limited. The total number of shares sold amounts to 5,80,02,545, representing a 3.09% reduction in the fund's shareholding. This divestment was conducted through open market operations.

Why this matters

This transaction signifies a material shift in Evexia Lifecare's shareholding structure. The sale by a substantial institutional investor could influence market sentiment and potentially increase the available shares for trading. As the seller is not a promoter, this action is seen as an independent investment decision and does not impact the company's management or promoter control.

The backstory

Prior to this sale, Zeal Global Opportunities Fund FCCB held 14,78,10,829 shares, constituting 7.87% of Evexia Lifecare's equity as of June 1, 2026. Following the open market sale, the fund's holding has decreased to 8,98,08,284 shares, now representing 4.78% of the company's total equity.

What changes now

The immediate impact is a reduction in the institutional holding by Zeal Global Opportunities Fund FCCB. The market float for Evexia Lifecare shares has potentially increased. Investors and market participants will be closely watching for any further disclosures or patterns in shareholding.

Risks to watch

While open market sales are common for funds, the scale of this transaction could lead to short-term price pressure if the selling continues or if it triggers further portfolio adjustments by other investors. The lack of specific guidance linked to the sale means the market will have to interpret the fund's motives.

Peer comparison

No direct peer comparison is immediately applicable from this filing alone, as it pertains to a specific institutional investor's transaction rather than company performance or strategy.

Context metrics (time-bound)

• Seller: Zeal Global Opportunities Fund FCCB
• Transaction Period: June 1, 2026 to June 8, 2026
• Shares Sold: 5,80,02,545
• Stake Reduction: 3.09%
• Holding Before Sale: 7.87%
• Holding After Sale: 4.78%

What to track next

Investors should monitor future shareholding pattern disclosures from Evexia Lifecare to see if Zeal Global Opportunities Fund FCCB continues its divestment or has completed its exit. Observing trading volumes and stock price movements will also be crucial.